𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Methotrexate versus azathioprine in rheumatoid arthritis

✍ Scribed by Jeurissen, M. E. C.

Publisher
Springer
Year
1994
Tongue
Dutch
Weight
482 KB
Volume
16
Category
Article
ISSN
1573-739X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Azathioprine in rheumatoid arthritis
Azathioprine in rheumatoid arthritis
✍ Thomas Hunter; Murray B. Urowitz; Duncan A. Gordon; Hugh A. Smythe; Metro A. Ogr πŸ“‚ Article πŸ“… 1975 πŸ› John Wiley and Sons 🌐 English βš– 466 KB πŸ‘ 1 views

## Abstract In 1973 we reported the beneficial effects of azathioprine in a double blind, cross‐over study in 17 patients with classic rheumatoid arthritis. During subsequent follow‐up over a mean period of 40 months, 4 patients had discontinued therapy because of poor therapeutic response and 1 be

Azathioprine in early rheumatoid arthrit
Azathioprine in early rheumatoid arthritis
✍ I. L. Dwosh; H. B. Stein; M. B. Urowitz; H. A. Smythe; M. A. Ogryzlo; T. Hunter πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 English βš– 571 KB
Methotrexate in rheumatoid arthritis
Methotrexate in rheumatoid arthritis
✍ Daniel E. Furst; Joel M. Kremer πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 1007 KB

Methotrexate (MTX) is effective in the treatment of refractory rheumatoid arthritis (RA). Its use by practitioners has become commonplace, even though it is not yet approved by the Food and Drug Administration for this use. One might assume, therefore, that there is a general understanding, among pr

Methotrexate in refractory rheumatoid ar
Methotrexate in refractory rheumatoid arthritis
✍ A. M. Th. Boerbooms; M. E. C. Jeurissen; A. A. A. Westgeest; H. Theunisse; L. B. πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 494 KB
Methotrexate in juvenile rheumatoid arth
Methotrexate in juvenile rheumatoid arthritis
✍ F. Albertioni; O. Beck; C. Peterson; B. FlatΓΈ; O. Vinje; S. Eksborg; P. Seideman πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 490 KB

Children with juvenile rheumatoid arthritis (JRA) have been reported to require higher doses (per kg body weight) of methotrexate (MTX) than adults with rheumatoid arthritis to control their disease. The purpose of the present study was to characterise the plasma pharmacokinetics of MTX and its majo